Calvert Holdings

CARY, NC (April 1, 2014).  Calvert Holdings, Inc. announced that Michael A. Recny, Ph.D., has been appointed Chief Executive Officer and has been elected a Director of the Company. He replaces Russ McLauchlan, who will become Executive Chairman and who will also now head the newly formed Executive Committee of Calvert Holdings, which will include Dr. Recny, Allan Reiss, […]

CARY, NC and HUMMELSTOWN, PA (October 1, 2013). Calvert Research, LLC and Oncoceutics, Inc. announced the execution of an Investment Partnership Agreement to support completion of preclinical studies for ONC201, Oncoceutics’ experimental anti-cancer compound. Under the terms of the Agreement, Calvert Research will utilize the extensive resources of its CRO affiliate, Calvert Laboratories, Inc., to complete animal pharmacology, […]

CARY, North Carolina (June 9, 2009). Calvert Research today announced the execution of a license agreement with Tulane University granting Calvert Research (through its wholly owned subsidiary, Calvert T1, LLC) certain rights to issued patents and patent applications covering a technology platform and novel compounds which have the potential to treat a debilitating eye disease […]